ApprovalTrail

Approval · Notice of Compliance 6409 · 1996

AERRANE: Notice of Compliance 6409

Issued December 16, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6409
Date
December 16, 1996
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Inhalation anaesthetic

Products in this notice

BrandDINStatus today
AERRANE02225875Marketed

Medicinal ingredients